Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

S Miyamoto, N Miyake, LF Jarskog… - Molecular …, 2012 - nature.com
Since the introduction of chlorpromazine and throughout the development of the new-
generation antipsychotic drugs (APDs) beginning with clozapine, the D 2 receptor has been …

Brain meets body: the blood-brain barrier as an endocrine interface

WA Banks - Endocrinology, 2012 - academic.oup.com
The blood-brain barrier (BBB) separates the central nervous system (CNS) from the
peripheral tissues. However, this does not prevent hormones from entering the brain, but …

Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological …

ER Samuels, E Szabadi - Current neuropharmacology, 2008 - ingentaconnect.com
The locus coeruleus (LC), the major noradrenergic nucleus of the brain, gives rise to fibres
innervating most structures of the neuraxis. Recent advances in neuroscience have helped …

[HTML][HTML] Pharmacological modulation of conditioned fear in the fear-potentiated startle test: a systematic review and meta-analysis of animal studies

L Groenink, PM Verdouw, Y Zhao, F Ter Heegde… - …, 2023 - Springer
Rationale and objectives Fear conditioning is an important aspect in the pathophysiology of
anxiety disorders. The fear-potentiated startle test is based on classical fear conditioning …

The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle

PD Shilling, D Feifel - Pharmacology Biochemistry and Behavior, 2008 - Elsevier
Preliminary evidence suggests that the neuropeptide, neurotensin (NT) may regulate
fear/anxiety circuits. We investigated the effects of PD149163, a NT1 receptor agonist, on …

Brain effects of chronic IBD in areas abnormal in autism and treatment by single neuropeptides secretin and oxytocin

MG Welch, TB Welch-Horan, M Anwar, N Anwar… - Journal of Molecular …, 2005 - Springer
Recent research points to the connection between behavioral and gut disorders. Early
adverse events are associated with inflammatory bowel disease (IBD). In animal models …

Secretin: a pleiotrophic hormone

JYS Chu, WH Yung, BKC Chow - … of the New York Academy of …, 2006 - Wiley Online Library
Secretin holds a unique place in the history of endocrinology and gastrointestinal
physiology, as it is the first peptide designated as a hormone. During the last century since …

Peripheral secretin-induced Fos expression in the rat brain is largely vagal dependent

H Yang, L Wang, SV Wu, J Tay, M Goulet, R Boismenu… - Neuroscience, 2004 - Elsevier
Iv injection of secretin activates neurons in brain areas controlling autonomic function and
emotion. Peripheral administration of secretin inhibits gastric functions through a central …

Age-related and regional differences in secretin and secretin receptor mRNA levels in the rat brain

J Tay, M Goulet, J Rusche, R Boismenu - Neuroscience letters, 2004 - Elsevier
In the present study expression levels of secretin and secretin receptor mRNAs in several
brain regions of rats ranging in age from postnatal days 7 to 60 were investigated by …

Multiple actions of secretin in the human body

IPY Lam, FKY Siu, JYS Chu, BKC Chow - International Review of Cytology, 2008 - Elsevier
The discovery of secretin initiated the field of endocrinology. Over the past century, multiple
gastrointestinal functions of secretin have been extensively studied, and it was discovered …